DCP logo

Dis-Chem Pharmacies Limited Stock Price

JSE:DCP Community·R26.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 29 Fair Values set on narratives written by author

DCP Share Price Performance

R29.85
-1.40 (-4.48%)
R27.75
Fair Value
R29.85
-1.40 (-4.48%)
7.6% overvalued intrinsic discount
R27.75
Fair Value
Price R29.85
AnalystLowTarget R27.75
AnalystConsensusTarget R40.04
AnalystHighTarget R43.10

DCP Community Narratives

·
Fair Value R27.75 7.6% overvalued intrinsic discount

Rising Costs Will Intensify Retail Saturation In South Africa

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value R39.7 24.8% undervalued intrinsic discount

Expanding Into Underrepresented Areas And Digital Health Will Strengthen Market Position In ZA Retail

1users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
·
Fair Value R43.1 30.7% undervalued intrinsic discount

Accelerated Store Rollouts Will Capture Aging And Digital Demand

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
R43.1
30.7% undervalued intrinsic discount
Revenue
11.98% p.a.
Profit Margin
2.89%
Future PE
33.38x
Price in 2029
R68
R27.75
7.6% overvalued intrinsic discount
Revenue
9% p.a.
Profit Margin
2.83%
Future PE
23.81x
Price in 2029
R43.75

Trending Discussion

No trending discussion available.

Updated Narratives

DCP logo

DCP: Dividend Reset And Margin Outlook Will Support Future Upside

Fair Value: R43.1 30.7% undervalued intrinsic discount
4 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
DCP logo

DCP: Reduced Dividend Payout Will Pressure Future Shareholder Returns

Fair Value: R27.75 7.6% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
DCP logo

Expanding Into Underrepresented Areas And Digital Health Will Strengthen Market Position In ZA Retail

Fair Value: R39.7 24.8% undervalued intrinsic discount
12 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Reasonable growth potential with adequate balance sheet.

2 Risks
2 Rewards

Dis-Chem Pharmacies Limited Key Details

R42.8b

Revenue

R33.4b

Cost of Revenue

R9.4b

Gross Profit

R8.4b

Other Expenses

R978.9m

Earnings

Last Reported Earnings
Feb 28, 2026
Next Reporting Earnings
n/a
1.14
21.97%
2.29%
64.9%
View Full Analysis

About DCP

Founded
1978
Employees
n/a
CEO
Rui Morais
WebsiteView website
dischemgroup.com

Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments: Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensaries, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also provides pharmaceutical, health, and front shop products in the wholesale market, health insurance products, occupational health clinics, and a psychological wellbeing platform. In addition, it offers customer loyalty programs. The company was founded in 1978 and is headquartered in Midrand, South Africa.

Recent DCP News & Updates

Narrative Update Jul 06

DCP: Dividend Reset And Margin Outlook Will Support Future Upside

Analysts have trimmed their price target for Dis-Chem Pharmacies to ZAR43.10 from ZAR46.20, citing updated assumptions for revenue growth, profit margins, and a slightly lower forward P/E multiple despite a reduced discount rate. What’s in the News for Dis-Chem Pharmacies Dis-Chem Pharmacies declared a gross final cash dividend of 15.91872 cents per share for the period ended 28 February 2026, aligned with its policy of paying out 40% of headline earnings.

Recent updates

No updates